# Int. VTE & Cancer Guidelines — ITAC VTE & cancer guidelines

> Medical guidelines for VTE prophylaxis and treatment in cancer patients. (iPhone/iPad app by Rachid Nouar.)

- Source: https://appshunter.io/ios/app/int-vte-and-cancer-guidelines/id929784725 (this page in markdown: same URL + `.md`)
- Developer: [Rachid Nouar](https://appshunter.io/developer/1439888403)
- Category: Medical, Education
- Price: Free
- Age rating: 17+
- Requires: iOS 11.0 · 26 MB
- Languages: English, French, Portuguese, Russian, Spanish
- Released: 2014-12-05
- Data updated: 2026-06-10
- Monetization: ad-supported
- User reviews in markdown: https://appshunter.io/ios/app/int-vte-and-cancer-guidelines/id929784725/reviews.md

## What is Int. VTE & Cancer Guidelines?

This application is available in English, French, Spanish, Portuguese, and Russian. The language of the app will be determined by the language setting of the user’s smartphone.

Based on international guidelines published in 2022, which were developed with methodological support from the Institut National du Cancer (INCa) in France and endorsed by the International Society on Thrombosis and Hemostasis (ISTH), this app is a practical step-by-step guide for the prophylaxis and treatment of venous thromboembolism (VTE: deep vein thrombosis (DVT), pulmonary embolism (PE), catheter-related thrombosis) in patients with cancer, including:
• Prophylaxis in hospitalized and ambulatory patients
• Recommendations for the treatment of both non-catheter and catheter-related VTE
• Specific recommendations related to special cancer situations
• Recommendations for initial, short-term, and long-term treatment

This treatment algorithm for anticoagulant use (low molecular weight heparins (LMWH), direct oral anticoagulants (DOAC), and vitamin K antagonists (VKA)) is intended for physicians and other healthcare professionals treating patients with cancer. It should not replace clinical judgement. It is based on clinical practice guidelines published in 2022:
Farge D*, Frere C*, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2022 Jul;23(7):e334-e347.

While these guidelines rely on the best available evidence at the time of publication, the clinician is advised to use clinical judgement when making decisions about prophylaxis and treatment of cancer-associated thrombosis (CAT).

APP AUTHORS / STEERING COMMITTEE
Professor Dominique Farge (France) (Co-Chair)
Professor James Douketis (Canada) (Co-Chair)
Dr Syed Abutalib (United States)
Professor Cihan Ay (Austria)
Dr Darko Antic (Serbia)
Professor Henri Bounameaux (Switzerland)
Professor Benjamin Brenner (Israel)
Dr Dialina Brilhante (Portugal)
Dr Patricis Casais (Argentina)
Dr Jean M. Connors (United States)
Professor Corinne Frere (France)
Professor Maria Cecilia Guillermo Esposito (Uruguay)
Professor Takayuki Ikezoe (Japan)
Professor Alok A. Khorana (United States)
Right Honourable Professor Lord Ajay Kakkar (United Kingdom)
Professor Luis Meillon-Garcia (Mexico)
Professor Andres Munoz-Martin (Spain)
Professor Ingrid Pabinger (Austria)
Dr Pedro Henrique Prata (Brazil)

ABOUT ITAC-CME
The International Initiative on Thrombosis and Cancer (ITAC-CME) is the international section of the Groupe Francophone Thrombose et Cancer (GFTC). A multidisciplinary group, the members of ITAC-CME are clinicians and researchers from across the globe, led by a core group of GFTC members. Through education of physicians, nurses, and allied health professionals, ITAC-CME is committed to disseminating relevant and peer-reviewed prophylaxis and treatment guidelines for VTE in cancer that will help to reduce a substantial economic burden on health care systems and improve the lives of millions of patients worldwide.

## Key features

- Step-by-step VTE prophylaxis and treatment guide
- Recommendations for anticoagulant use
- Covers hospitalized and ambulatory patients
- Addresses catheter-related thrombosis
- Specific recommendations for cancer situations
- Based on 2022 international guidelines

## Recent user reviews (1 of 1)

All indexed reviews: https://appshunter.io/ios/app/int-vte-and-cancer-guidelines/id929784725/reviews.md

### 5/5 — Great app for healthcare professionals

*2015-09-02*

Easy to use and helpful, waiting for other countries to be added!

## Frequently asked questions about Int. VTE & Cancer Guidelines

### What is the Int. VTE & Cancer Guidelines app?

The Int. VTE & Cancer Guidelines app provides a practical, step-by-step guide for the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer. It is based on international guidelines published in 2022.

### Who is the Int. VTE & Cancer Guidelines app for?

This app is intended for physicians and other healthcare professionals treating patients with cancer. It should be used to inform clinical judgment, not replace it.

### What languages does the Int. VTE & Cancer Guidelines app support?

The app is available in English, French, Spanish, Portuguese, and Russian. The language used will automatically adjust to the user's smartphone language settings.

### Does Int. VTE & Cancer Guidelines have ads?

Yes, the Int. VTE & Cancer Guidelines app contains advertisements.

### What specific VTE scenarios does the app cover?

The app covers prophylaxis in both hospitalized and ambulatory patients, recommendations for treating non-catheter and catheter-related VTE, and specific recommendations for special cancer situations.

### What type of anticoagulants are covered in the Int. VTE & Cancer Guidelines app?

The treatment algorithm includes recommendations for low molecular weight heparins (LMWH), direct oral anticoagulants (DOAC), and vitamin K antagonists (VKA).

### On which devices can I use the Int. VTE & Cancer Guidelines app?

The Int. VTE & Cancer Guidelines app is available for iPhone, iPad, and iPod. It is rated for users aged 17 and older.

### When was the Int. VTE & Cancer Guidelines app last updated?

The app was last updated on June 22, 2023, with version 2.0.1.

## Version history (last 5 releases)

### 2.0.1 — 2023-06-22

- Update based on the 2022 ITAC international guidelines
- Various bug fixes

### 2.0.0 — 2023-05-16

Latest version of guidelines

### 1.7.0 — 2021-04-24

- All accounts related operations now use the new website accounts.itaccme.com
- Various bug fixes

### 1.5.2 — 2020-12-16

- Addition of Russian and Portuguese versions
- Various bug fixes

### 1.5.1 — 2019-10-22

Updated ITAC international clinical practice recommendations to 2019 version;
Bug fixes and various improvements.

## Apps similar to Int. VTE & Cancer Guidelines

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [AcuteCare Toolkit](https://appshunter.io/ios/app/acutecare-toolkit/id909347184) | — | Free | Medical |
| [Seno K'App](https://appshunter.io/ios/app/seno-kapp/id1616867059) | — | Free | Medical |
| [eGVHD](https://appshunter.io/ios/app/egvhd/id1355873791) | 5.0 (2) | Free | Medical |
| [HemeOncBuddy](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336) | 5.0 (17) | Free | Medical |
| [myWAPPS](https://appshunter.io/ios/app/mywapps/id1404681825) | 5.0 (1) | Free | Medical |
| [My Vascular Access](https://appshunter.io/ios/app/my-vascular-access/id1571764113) | 5.0 (1) | Free | Medical |

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-06-10.*